Doctors are warning about a bacterial vaginostosis (VV) condition affecting more than half a million people in the U.S. that can lead to pneumonia and chronic lung damage.

Vaginal bacteria are usually found in the nose and mouth, but they can also be found in other parts of the body, including the mouth, intestines and throat.

They are also found in high concentrations in the bloodstream and in the lungs.

According to the Centers for Disease Control and Prevention, about 2.4 million people have a condition called VV.

The condition affects people who have not yet developed a virus infection.

In addition to breathing problems, it can also cause heart and other health problems, as well as lead to infection with other viruses.

The VV condition affects about 50,000 Americans.

The most common cause of VV is pneumonia, which can cause pneumonia, bronchitis and other symptoms.

About one in every five people with VV has an underlying health problem that could lead to other conditions, including asthma, diabetes and other chronic conditions.

Vegans who suffer from VV have been urged to seek help from a health care provider and get regular tests.

Vaseline can be used to treat VV infections.

But the FDA has not yet issued any guidelines on how to use it to treat vaginismus, a condition caused by VV, in the United States.

The FDA says there are no specific medications or treatments that work well for VV patients, but it does recommend that people with the condition consult with a health provider for treatment.

The U.K. and France have banned the use of vaseline and other products to treat symptoms of VLPs.

In the U!

States, doctors have recommended using an enzyme-blocking drug called ritonavir, also known as Ritonavirus-1, or other methods of treating symptoms such as sore throats and fever.

But a study published in the Journal of Clinical Investigation in December found no benefit of ritonovir in preventing VV from spreading in the lung.

The new research, conducted by researchers at the University of California, San Francisco, also found no effect of rionavir on bacterial vagosis, a viral infection that causes painful, white discharge from the vagina.